Figure 2.

The expression of MMP-2 in clinical stage I and clinical stage III ovarian carcinoma. A, MMP-2 was weakly expressed in Clinical stage I ovarian carcinoma; B, MMP-2 was strongly expressed in clinical stage III ovarian carcinoma. [bar line = 50 μm].

Wang et al. Diagnostic Pathology 2013 8:190   doi:10.1186/1746-1596-8-190
Download authors' original image